New Review Advances Understanding of Ménière’s Disease and Points to More Targeted Treatments
en-GBde-DEes-ESfr-FR

New Review Advances Understanding of Ménière’s Disease and Points to More Targeted Treatments

07/08/2026 Compuscript Ltd

A comprehensive new review is bringing together the latest advances in Ménière’s disease, offering a clearer picture of the biological mechanisms that may drive this complex inner ear disorder while highlighting new directions for diagnosis, disease modeling, and treatment. The article proposes that the endolymphatic sac, a structure involved in maintaining the inner ear environment, may represent the central site where multiple disease-triggering factors converge, providing a unifying explanation for the diverse symptoms experienced by patients.
Ménière’s disease is a chronic condition characterized by recurring episodes of vertigo, fluctuating hearing loss, tinnitus, and a feeling of fullness in the ear. Although the disease has been recognized for more than a century, its underlying cause has remained uncertain. The review explains that rather than arising from a single mechanism, the disorder is likely influenced by a combination of genetic susceptibility, immune dysfunction, viral infection, inflammation, impaired ion regulation, and abnormalities in inner ear fluid balance. These diverse factors may ultimately disrupt the function of the endolymphatic sac, leading to the development of endolymphatic hydrops, the hallmark pathological feature of the disease.
The article also examines the strengths and limitations of current animal models, noting that while existing models have improved understanding of disease mechanisms, none fully reproduces the fluctuating symptoms seen in patients. The review suggests that combining surgical, biological, and genetic approaches may produce more representative models and accelerate the development of new therapies.
Rapid advances in multi-omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, are also transforming the field. These approaches have identified molecular pathways linked to immune activation, oxidative stress, abnormal ion transport, extracellular matrix remodeling, and altered nerve signaling. Together, these findings are helping to identify potential biomarkers that could improve diagnosis while revealing new therapeutic targets.
The review highlights growing evidence that the immune system plays an important role in disease progression. Inflammatory signaling, allergic responses, viral infections, and even changes in the inner ear microbiome may contribute to damage within the endolymphatic sac. At the same time, genetic discoveries are uncovering inherited variants associated with both familial and sporadic forms of the disease, further supporting the involvement of pathways controlling fluid regulation and sensory cell function.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 10.4 |Impact Factor:14.6
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to Genes & Diseases may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (https://x.com/GenesNDiseases)
# # # # # #
Reference
Siyuan Liu, Yanshi Li, Yuting Zhang, Yuxiao Zheng, Chen Jin, Lin Chen, Guohua Hu, Wenqi Zuo, Research progress on the mechanisms and animal models of Ménière’s disease, Genes & Diseases, Volume 13, Issue 5, 2026, 102022, https://doi.org/10.1016/j.gendis.2025.102022

Funding
Natural Science Foundation of Chongqing, China CSTB2024NSCQ-MSX1014
Siyuan Liu, Yanshi Li, Yuting Zhang, Yuxiao Zheng, Chen Jin, Lin Chen, Guohua Hu, Wenqi Zuo, Research progress on the mechanisms and animal models of Ménière’s disease, Genes & Diseases, Volume 13, Issue 5, 2026, 102022, https://doi.org/10.1016/j.gendis.2025.102022
Attached files
  • Image Caption: Summary of current sequencing methods for patients with Me´nie`re’s disease.Image link https://ars.els-cdn.com/content/image/1-s2.0-S2352304225005112-gr1_lrg.jpg
  • Image Caption: Hypothetical schematic diagram of the immune mechanism in Meniere’s disease. Image link: https://ars.els-cdn.com/content/image/1-s2.0-S2352304225005112-gr2_lrg.jpg
07/08/2026 Compuscript Ltd
Regions: Europe, Ireland, Asia, China
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by AlphaGalileo Terms Of Use Privacy Statement